Your search returned 2 results.

Results
	1.	Phase 2 Study of Dose-Dense Doxorubicin and Cyclophosphamide Followed by Eribulin Mesylate With or Without Prophylactic Growth Factor for Adjuvant Treatment of Early-Stage Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer. [electronic resource] by Cadoo, Karen A Kaufman, Peter A Seidman, Andrew D Chang, Cassandra Xing, Dongyuan Traina, Tiffany A Producer: 20190909 In: Clinical breast cancer vol. 18 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Risk factors and outcomes associated with the isolation of polymyxin B and carbapenem-resistant Enterobacteriaceae spp.: A case-control study. [electronic resource] by Teo, Jocelyn Qi-Min Chang, Cassandra Wee-Ting Leck, Hui Tang, Cheng-Yee Lee, Shannon Jing-Yi Cai, Yiying Ong, Rick Twee-Hee Koh, Tse-Hsien Tan, Thuan-Tong Kwa, Andrea Lay-Hoon Producer: 20190808 In: International journal of antimicrobial agents vol. 53 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search